News

Integrated Diagnostics Holdings plc (IDH) is an LSE Main Market listed leading diagnostics services provider across the Middle East and Africa, operating in Egypt, Jordan, Nigeria, Saudi Arabia and Sudan. Through well-established brands including Al Borg, Al Mokhtabar and Biolab, the Group offers more than 3,000 clinical pathology and radiology tests.

With over 40 years of experience, IDH has built a strong reputation for quality and internationally recognised accreditations. As at 31 December 2024, the Group operated 628 branches, serving more than 8.9 million patients and performing over 39.2 million tests during the year. Listed on the London Stock Exchange since 2015, IDH continues to expand through organic growth and targeted acquisitions across high-growth healthcare markets.

Hena Holdings Ltd. is a privately held investment company incorporated in the British Virgin Islands. It is wholly owned by Dr. Hend El Sherbini and her mother, Dr. Moamena Abdul Wahab Kamel.

On 23 June 2026, Hena Holdings, announced that it had acquired 126,000,000 IDH Shares from Actis IDH Limited, an entity controlled by funds managed by Elliott Investment Management L.P.  and that, as a result of the Elliott Transaction, under Rule 9 of the Takeover Code, it was required to make a mandatory cash offer for the IDH Shares not already held by them.

Publication of Offer Document

The Perivan shareholder communications team was delighted to work with Strand Hanson who acted as Financial Adviser and Rule 3 Adviser to IDH on the offer and ancillary documents which were successfully published and posted to qualifying shareholders on 8 July 2026.

For further information, click here.

Perivan specialise in producing and publishing financial documents relating to shareholder and investor communications for quoted companies and are a market leader for the production of documentation relating to Mergers & Acquisitions.